Intro
Shortly after being diagnosed with Type 1 diabetes, many people experience a period during which their condition unexpectedly becomes easier to manage. Insulin requirements fall, blood glucose levels stabilise, and for some people it may feel as though the diabetes has improved — or even disappeared.
This period is called the honeymoon phase. It is real, it is common, and it can be confusing. The most important thing to understand is that it does not mean the diabetes is gone or in remission. The autoimmune process that causes Type 1 diabetes continues throughout the honeymoon phase, and insulin will be needed for life — even when it feels like it might not be.
Key Points
- The honeymoon phase is a temporary period of reduced insulin requirements that occurs in many people shortly after Type 1 diabetes is diagnosed.
- It happens because some insulin-producing beta cells survive the initial immune attack and recover partial function once blood glucose is brought under control.
- It is not remission. The immune system continues destroying the remaining beta cells throughout the honeymoon phase.
- Insulin must not be stopped during the honeymoon phase — doing so carries a serious risk of diabetic ketoacidosis (DKA), even when glucose levels feel stable.
- The phase can last weeks to months, or occasionally longer, and ends when the remaining beta cells are fully depleted.
- Not everyone experiences a honeymoon phase, and its absence does not indicate anything is wrong with your management.
What Is the Honeymoon Phase?
The honeymoon phase — also called the partial remission phase — is a temporary period following the diagnosis of Type 1 diabetes in which the body’s remaining insulin-producing cells recover some function. This leads to reduced insulin requirements and, often, noticeably more stable blood glucose compared to the period immediately after diagnosis.
It is called a “honeymoon” because it can feel like a welcome improvement: the intense work of the early post-diagnosis period — frequent monitoring, dose adjustments, and unpredictable glucose — temporarily eases.
The phase is partial, not complete. The pancreas is not recovering fully. The immune attack on the beta cells has not stopped. What is happening is that the cells that survived the initial attack are working better now that blood glucose levels are closer to normal — high glucose is itself toxic to beta cells, and reducing it with insulin allows the remaining cells to function more effectively for a time.
Why It Happens
Type 1 diabetes is an autoimmune condition in which the immune system attacks and destroys the insulin-producing beta cells in the pancreas. At the time of diagnosis, most — but not all — of those cells have already been destroyed.
When insulin therapy begins and blood glucose is brought under control, two things happen that support the remaining beta cells:
-
Reduced glucose toxicity — chronically high blood glucose is damaging to beta cells. When insulin treatment lowers blood glucose, this toxic burden is reduced, and the surviving cells can recover some of their function.
-
Partial restoration of insulin secretion — the remaining beta cells, now operating in a less hostile environment, can produce meaningful amounts of insulin again, even if temporarily.
The result is that the body is producing more of its own insulin than it was at diagnosis, on top of the insulin being administered. This is why insulin requirements fall — sometimes substantially.
How Long It Lasts
The honeymoon phase is highly variable. For some people it lasts only a few weeks; for others it persists for a year or more. No reliable test or predictor can tell you in advance how long your honeymoon phase will last.
Several factors influence duration:
- Age at diagnosis — older adolescents and adults tend to have a more prolonged honeymoon phase than very young children
- Degree of beta cell preservation at diagnosis — the more surviving cells, the longer the phase may last
- Quality of glucose control — maintaining good blood glucose control during the honeymoon phase may help preserve the remaining beta cells for longer
The phase ends gradually, not abruptly. As the immune system continues destroying the remaining beta cells, their output declines and insulin requirements begin to rise again. This is a normal part of the progression of Type 1 diabetes.
What It Feels Like
During the honeymoon phase, people often notice:
- Lower insulin requirements — doses that were working well immediately after diagnosis may start to cause lows, requiring reduction
- More stable blood glucose — the body’s own insulin production smooths out fluctuations in a way that injected insulin alone often cannot
- Fewer unexpected lows and highs — glucose becomes more predictable day to day
- A sense that the diabetes is easier — less correction needed, fewer alarms, more flexibility
This can be a welcome relief after the intense period of adjustment following a new diagnosis. It can also be misleading.
Why It Can Be Misleading
The improvement during the honeymoon phase is real — but it is not what it can feel like. The temptation to interpret it as recovery, remission, or even a misdiagnosis is understandable, but it is dangerous.
“I feel better” does not mean the disease has resolved. The immune attack on the beta cells has not stopped. The residual insulin production that is making things easier is temporary and will diminish as more cells are lost.
The most serious risk is stopping or significantly reducing insulin without medical guidance. Even during the honeymoon phase, when the body is producing some insulin of its own, the amount is insufficient to safely maintain blood glucose without supplementation. Without adequate insulin:
- Blood glucose can rise rapidly, often without obvious early symptoms
- The body begins breaking down fat for energy, producing ketones
- This can progress to diabetic ketoacidosis (DKA) — a medical emergency
This risk exists even for people in the middle of a pronounced honeymoon phase. The body’s residual insulin production is not reliable or consistent enough to replace prescribed insulin therapy.
The honeymoon phase can also lead to under-correction of high glucose — a person might assume their glucose will come down on its own as it has been doing, and delay treatment longer than is safe.
Do You Still Need Insulin?
Yes — insulin must continue throughout the honeymoon phase.
Even if your insulin requirements have fallen significantly, stopping insulin is not safe and should never be done without explicit guidance from your diabetes team. This applies even if your blood glucose appears well-controlled.
What may change is how much insulin you need — your team may reduce your doses to reflect the additional insulin your own beta cells are contributing. Dose decisions should always be made with your diabetes team based on your glucose data, not made independently at home.
If you are experiencing frequent low blood glucose during the honeymoon phase, speak with your team — they can review your doses safely. For more on how insulin is administered and how doses are managed, see Insulin Administration.
Risks of Misunderstanding the Honeymoon Phase
The consequences of misinterpreting the honeymoon phase as recovery can be serious:
Diabetic Ketoacidosis (DKA)
If insulin is stopped or significantly reduced without medical guidance, blood glucose can rise and ketones can accumulate. DKA can develop within hours and is a medical emergency requiring hospital treatment. It can occur even when the body is producing some insulin, because that production is partial and unreliable.
If you experience any symptoms of DKA — nausea, vomiting, abdominal pain, rapid breathing, fruity-smelling breath — seek emergency medical attention immediately. See DKA Quick Reference for warning signs and when to act.
Accelerated Beta Cell Loss
Uncontrolled hyperglycaemia — blood glucose that rises because insulin has been stopped or reduced too far — is toxic to the remaining beta cells. This can shorten the honeymoon phase and accelerate the loss of the residual insulin production that was providing some benefit. Maintaining good glucose control during the honeymoon phase is one of the few things that may help preserve remaining beta cell function for longer.
Practical Advice
Continue monitoring closely. The honeymoon phase can make glucose feel stable, but variability is still present. Regular monitoring — and CGM if available — helps you and your diabetes team track what is actually happening rather than relying on how things feel.
Work closely with your diabetes team. As insulin requirements change during the honeymoon phase, dose adjustments will likely be needed. These should be guided by your team, not made independently. If you find your doses are consistently causing lows, contact your team — this is expected during the honeymoon phase and is something they will want to know about and manage with you.
Expect the phase to end. Being prepared for the eventual end of the honeymoon phase avoids it feeling like a setback when it happens. When glucose levels begin to fluctuate more and insulin requirements rise again, this is a normal part of Type 1 diabetes progression, not a sign that anything has gone wrong. Your team will adjust your management plan as your needs evolve.
If you were newly diagnosed recently, the honeymoon phase is one of many reasons why close contact with your diabetes team in the first months is particularly important. The transition from the honeymoon phase back to full insulin dependence benefits from careful review and support.
FAQ
Q: Can Type 1 diabetes go away during the honeymoon phase? No. The honeymoon phase can make Type 1 diabetes feel much more manageable — insulin needs drop and glucose stabilises — but the autoimmune condition has not resolved. The immune system continues destroying the remaining beta cells throughout this period. When those cells are fully depleted, insulin requirements rise again. Type 1 diabetes is permanent; insulin will be needed for life.
Q: How do I know if I am in the honeymoon phase? The clearest sign is a reduction in insulin requirements compared to immediately after diagnosis, along with more stable blood glucose levels. There is no specific test — your diabetes team will recognise it through your glucose patterns and insulin usage over time. If you are finding that your usual doses are causing unexpected lows, discuss this with your team.
Q: Can I stop insulin during the honeymoon phase? No. Even when insulin requirements fall substantially, stopping insulin is not safe and carries a real risk of DKA — a life-threatening emergency — even when glucose levels currently feel stable. Any changes to your insulin regimen during the honeymoon phase should be made by your diabetes team, not independently.
Q: How long does the honeymoon phase last? It varies considerably — typically weeks to months, and in some people (particularly older adolescents and adults) a year or more. There is no reliable way to predict its duration in advance. It ends gradually as the remaining beta cells are depleted and insulin requirements begin to rise.
Q: Does everyone experience a honeymoon phase? Not everyone. It is common — particularly in older children, adolescents, and adults — but does not occur in all cases. Very young children may have a shorter or less noticeable phase. Whether or not you experience it has no bearing on your long-term outlook or management requirements.